Chuanying Y. Geng
Workers Stadium South Road
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Venetoclax, azacitidine, and G-CSF targeting molecular residual disease in CBFB::MYH11 AML resistant to high-dose cytarabine.
Journal: Blood cancer journal
Published: March 30, 2026
CAR-T therapy moving to first-line in multiple myeloma: latest updates from the 2025 ASH annual meeting.
Journal: Journal of hematology & oncology
Published: January 17, 2026
Clinical Characteristics and Prognostic Value of Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma Patients in China.
Journal: Journal of blood medicine
Published: December 30, 2024
Analysis of the prognostic factors in primary plasma cell leukemia in the era of novel agents
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: September 04, 2024
Comparison of etoposide combined with G-CSF and cyclophosphamide combined with G-CSF in the mobilization of autologous peripheral blood stem cells in patients with multiple myeloma
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: July 01, 2024
Paired comparisons of venetoclax concentration in cerebrospinal fluid, bone marrow, and plasma in acute leukemia patients.
Journal: Clinical and translational science
Published: April 28, 2024
Characteristics and outcomes of secondary acute lymphoblastic leukemia (sALL) after multiple myeloma (MM): SEER data analysis in a single-center institution.
Journal: Cancer pathogenesis and therapy
Published: April 24, 2024
Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients.
Journal: Journal of clinical laboratory analysis
Published: March 03, 2024
Prognostic value of the Second Revision of the International Staging System in patients with newly diagnosed transplant-eligible multiple myeloma
Journal: Zhonghua nei ke za zhi
Published: January 08, 2024
Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma.
Journal: Journal of personalized medicine
Published: March 05, 2023
Last Updated: 09/26/2026